American Oncology Network, Inc.
AONC
$6.01
$0.010.17%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.74B | 1.58B | 1.45B | 1.33B | 1.27B |
| Total Other Revenue | 15.51M | 14.01M | 13.32M | 14.34M | 13.47M |
| Total Revenue | 1.76B | 1.59B | 1.46B | 1.34B | 1.28B |
| Cost of Revenue | 2.09B | 1.51B | 1.38B | 1.27B | 1.19B |
| Gross Profit | 163.01M | 86.65M | 75.53M | 69.71M | 85.51M |
| SG&A Expenses | 170.76M | 130.35M | 120.81M | 107.99M | 103.43M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.78B | 1.64B | 1.50B | 1.38B | 1.30B |
| Operating Income | -16.09M | -43.70M | -45.28M | -38.28M | -17.92M |
| Income Before Tax | -24.46M | -49.08M | -61.20M | -56.27M | -35.69M |
| Income Tax Expenses | 2.50M | 2.64M | 2.95M | 3.28M | 384.00K |
| Earnings from Continuing Operations | -26.96 | -51.72 | -64.16 | -59.55 | -36.07 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 22.99M | 42.68M | 54.39M | 47.65M | 30.53M |
| Net Income | -3.97M | -9.04M | -9.76M | -11.90M | -5.54M |
| EBIT | -16.09M | -43.70M | -45.28M | -38.28M | -17.92M |
| EBITDA | -5.58M | -34.16M | -36.25M | -29.54M | -9.47M |
| EPS Basic | -1.29 | -2.03 | -2.45 | -2.46 | -1.24 |
| Normalized Basic EPS | 0.90 | 1.62 | 3.05 | 2.35 | 1.88 |
| EPS Diluted | -1.53 | -2.27 | -2.69 | -2.46 | -1.24 |
| Normalized Diluted EPS | 0.63 | 1.35 | 2.79 | 2.35 | 1.88 |
| Average Basic Shares Outstanding | 55.46M | 39.07M | 32.42M | 34.26M | 26.73M |
| Average Diluted Shares Outstanding | 81.17M | 64.78M | 58.13M | 34.26M | 26.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -104.88% | -110.50% | -159.38% | -342.13% |